Free Trial
→ Trump to unlock 15-figure fortune for America (May 3rd) ? (From Paradigm Press) (Ad) Buy NRBO Stock  Free NRBO Stock Alerts

NeuroBo Pharmaceuticals (NRBO) Short Interest Ratio & Short Volume

NeuroBo Pharmaceuticals logo
$1.58 +0.02 (+0.96%)
As of 03/28/2025
Compare

NeuroBo Pharmaceuticals Short Interest Data

NeuroBo Pharmaceuticals (NRBO) has a short interest of 34,300 shares, representing 1.14% of the float (the number of shares available for trading by the public). This marks a 78.65% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.8, indicating that it would take 0.8 days of the average trading volume of 46,263 shares to cover all short positions.

Current Short Interest
34,300 shares
Previous Short Interest
19,200 shares
Change Vs. Previous Month
+78.65%
Dollar Volume Sold Short
$76,146.00
Short Interest Ratio
0.8 Days to Cover
Last Record Date
November 15, 2024
Outstanding Shares
8,616,000 shares
Float Size
3,000,000 shares
Short Percent of Float
1.14%
Today's Trading Volume
36,733 shares
Average Trading Volume
46,263 shares
Today's Volume Vs. Average
79%
Short Selling NeuroBo Pharmaceuticals?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for NeuroBo Pharmaceuticals and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

NRBO Short Interest Over Time

NRBO Days to Cover Over Time

NRBO Percentage of Float Shorted Over Time

Remove Ads

NeuroBo Pharmaceuticals Short Interest History

Export to Excel
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
11/15/202434,300 shares $76,146.00 +78.7%1.1%0.8 $2.22
10/31/202419,200 shares $49,344.00 -20.3%0.6%0.5 $2.57
10/15/202424,100 shares $60,973.00 -25.6%0.8%0.6 $2.53
9/30/202432,400 shares $102,708.00 -2.7%1.1%0.8 $3.17
9/15/202433,300 shares $120,213.00 +18.5%1.1%0.6 $3.61
8/31/202428,100 shares $103,689.00 -35.6%1.0%0.5 $3.69
8/15/202443,600 shares $170,476.00 +32.9%1.6%0.9 $3.91
7/31/202432,800 shares $133,496.00 -37.8%10.1%0.5 $4.07
7/15/202452,700 shares $263,500.00 -43.1%16.2%0.9 $5.00
6/30/202492,600 shares $448,184.00 +58.3%41.3%1.6 $4.84
6/15/202458,500 shares $222,885.00 -6.9%2.9%1.3 $3.81
5/31/202462,800 shares $239,268.00 +74.9%3.1%1.4 $3.81
5/15/202435,900 shares $152,216.00 -11.6%1.8%0.3 $4.24
4/30/202440,600 shares $133,980.00 -21.8%2.1%0.3 $3.30
4/15/202451,900 shares $183,207.00 -16.2%2.6%0 $3.53
3/31/202461,900 shares $253,171.00 -9.5%1.9%0 $4.09
3/15/202468,400 shares $314,640.00 +67.2%2.2%0.1 $4.60
2/29/202440,900 shares $236,811.00 -68.9%1.3%0 $5.79
2/15/2024131,700 shares $636,111.00 +395.1%4.1%0.1 $4.83
1/31/202426,600 shares $86,982.00 +39.3%0.8%0 $3.27
1/15/202419,100 shares $64,558.00 +180.9%0.4%0.6 $3.38
12/31/20236,800 shares $25,136.88 +15.3%0.2%0.2 $3.70
12/15/20235,900 shares $23,590.56 -90.1%0.2%0.5 $4.00
11/30/202359,600 shares $26,700.80 -31.8%N/A1 $0.45
11/15/202387,400 shares $37,599.48 -2.7%N/A1.3 $0.43
10/31/202389,800 shares $37,805.80 -29.5%N/A0.8 $0.42
10/15/2023127,400 shares $60,757.06 +4.3%N/A0.8 $0.48
9/30/2023122,200 shares $58,167.20 +11.1%N/A0.5 $0.48
9/15/2023110,000 shares $59,367.00 -20.1%N/A0.3 $0.54
8/31/2023137,700 shares $61,290.27 -48.0%0.8%0.4 $0.45
8/15/2023265,000 shares $163,770.00 +217.4%1.5%0.7 $0.62
7/31/202383,500 shares $42,835.50 -57.9%0.7%0.2 $0.51
7/15/2023198,500 shares $86,645.25 -67.5%1.5%0.5 $0.44
6/30/2023611,400 shares $267,242.94 +224.5%4.6%1.3 $0.44
6/15/2023188,400 shares $93,069.60 -20.6%1.4%0.5 $0.49
5/31/2023237,400 shares $132,944.00 -9.0%1.8%0.6 $0.56
5/15/2023261,000 shares $154,746.90 +15.6%2.0%0.5 $0.59
4/30/2023225,800 shares $144,512.00 +33.9%1.7%0.4 $0.64
4/15/2023168,600 shares $123,078.00 -26.5%2.3%0.2 $0.73
3/31/2023229,300 shares $162,871.79 -13.3%3.1%0.3 $0.71
Elon’s ‘Strike Squad’ sends these 9 stocks soaring? (Ad)

Elon Musk's DOGE 'strike squad' just revealed it's speeding up the rollout of a radical technology across the federal government. And that's creating a huge buying opportunity for the stocks involved. Put simply, under Elon's watchful eye, the U.S. government is rapidly adopting AI technology. And that's sending certain stocks soaring higher.

Here's how to get our 9-stock buy list immediately.
3/15/2023264,500 shares $177,320.80 +28.1%4.2%0.2 $0.67
2/28/2023206,500 shares $132,160.00 -40.9%3.3%0.1 $0.64
2/15/2023349,400 shares $251,218.60 -46.1%5.6%0.1 $0.72
1/31/2023648,700 shares $512,473.00 +359.7%10.3%0.2 $0.79
1/15/2023141,100 shares $108,618.78 -85.3%2.2%0 $0.77
12/30/2022958,400 shares $687,652.00 -14.4%15.3%0.3 $0.72
12/15/20221,120,000 shares $1.69 million +29.4%N/A0.3 $1.51
11/30/2022865,400 shares $1.25 million -47.6%N/A0.3 $1.45
11/15/20221,650,000 shares $2.34 million +837.0%45.1%0.6 $1.42
10/31/2022176,100 shares $1.35 million +257.2%9.2%0.1 $7.68
10/15/202249,300 shares $628,575.00 -46.8%9.6%0.1 $12.75
9/30/202292,600 shares $1.27 million -12.3%17.9%0.2 $13.69
9/15/2022105,600 shares $2.62 million -34.5%24.7%0.2 $24.82
8/31/2022161,300 shares $51,422.44 -7.5%1.3%0.1 $0.32
8/15/2022174,400 shares $71,172.64 -5.4%1.4%2 $0.41
7/31/2022184,300 shares $77,664.02 -17.7%1.4%1.9 $0.42
7/15/2022223,900 shares $125,406.39 +2.8%1.9%1.9 $0.56
6/30/2022217,900 shares $104,548.42 +17.2%1.9%1.7 $0.48
6/15/2022186,000 shares $74,772.00 -7.4%1.6%1.4 $0.40
5/31/2022200,900 shares $89,199.60 -15.8%1.7%1 $0.44
5/15/2022238,500 shares $121,444.20 -13.1%2.1%1.3 $0.51
4/30/2022274,400 shares $176,439.20 -8.8%2.4%1.5 $0.64
4/15/2022301,000 shares $261,659.30 -7.9%2.6%1.6 $0.87
3/31/2022326,900 shares $294,896.49 +31.6%2.9%1.6 $0.90
3/15/2022248,500 shares $191,842.00 +9.2%2.2%0.4 $0.77
2/28/2022227,500 shares $179,725.00 -6.0%2.0%0.4 $0.79
2/15/2022242,100 shares $225,153.00 -35.7%2.1%0.4 $0.93
1/31/2022376,500 shares $391,560.00 -9.5%3.3%0.6 $1.04
1/15/2022416,000 shares $544,960.00 +423.9%3.6%0.6 $1.31
12/31/202179,400 shares $96,868.00 +44.9%0.7%0.1 $1.22
12/15/202154,800 shares $76,720.00 -34.7%0.5%0.1 $1.40
11/30/202183,900 shares $135,079.00 +75.5%0.7%0.2 $1.61
11/15/202147,800 shares $87,474.00 -53.9%0.4%0.1 $1.83
10/29/2021103,600 shares $183,372.00 -77.5%1.1%0.2 $1.77
10/15/2021460,600 shares $875,140.00 +340.8%4.9%0.8 $1.90
9/30/2021104,500 shares $388,740.00 -11.1%1.1%0 $3.72
9/15/2021117,600 shares $453,936.00 -18.8%1.5%0.1 $3.86
8/31/2021144,800 shares $599,472.00 -40.8%1.8%0.1 $4.14
8/13/2021244,500 shares $865,530.00 -43.0%3.1%0.1 $3.54
7/30/2021429,200 shares $1.41 million +122.4%5.4%0.2 $3.29
7/15/2021193,000 shares $528,820.00 -14.8%2.5%0.1 $2.74
6/30/2021226,400 shares $753,912.00 -52.8%2.9%0.9 $3.33
6/15/2021479,300 shares $1.60 million +18.8%6.2%1.9 $3.34
5/28/2021403,400 shares $1.14 million +7.1%5.3%3.3 $2.82
5/14/2021376,600 shares $1.04 million +4.8%4.9%2.6 $2.77
4/30/2021359,300 shares $1.28 million +4.3%4.7%1.7 $3.56
4/15/2021344,500 shares $1.30 million +8.4%4.5%0.9 $3.76
3/31/2021317,800 shares $1.35 million +143.3%4.2%0.8 $4.26
3/15/2021130,600 shares $578,558.00 -6.6%1.7%0.3 $4.43
2/26/2021139,800 shares $648,672.00 -42.1%1.6%0.4 $4.64
Trump to unlock 15-figure fortune for America (May 3rd) ? (Ad)

We were shown this map by former Presidential Advisor, Jim Rickards, one of the most politically connected men in America. Rickards has spent his fifty-year career in the innermost circles of the U.S. government and banking. And he believes Trump could soon release this frozen asset to the public.

But something even more spectacular is bound to happen. And those who know what to expect could make
2/12/2021241,500 shares $1.34 million -73.3%2.7%0.7 $5.53
1/29/2021902,900 shares $5.16 million +545.4%14.3%2.9 $5.72
1/15/2021139,900 shares $864,582.00 +2.6%2.2%1.3 $6.18
12/31/2020136,400 shares $754,292.00 +11.7%2.9%2.2 $5.53
12/15/2020122,100 shares $667,887.00 -3.3%2.2%6.9 $5.47
11/30/2020126,300 shares $684,546.00 -0.8%2.3%8 $5.42
11/15/2020127,300 shares $669,598.00 +1.9%2.3%7.4 $5.26
10/30/2020124,900 shares $666,966.00 -5.5%2.2%6.8 $5.34
10/15/2020132,200 shares $831,538.00 -1.9%2.4%4.6 $6.29
9/30/2020134,800 shares $757,576.00 +7.8%2.4%3.2 $5.62
9/15/2020125,100 shares $783,126.00 -17.0%2.2%1.9 $6.26
8/31/2020150,700 shares $916,256.00 -11.4%2.7%2.1 $6.08
8/14/2020170,100 shares $1.12 million -16.0%3.1%2.3 $6.57
7/31/2020202,500 shares $1.30 million -34.7%3.7%2.9 $6.41
7/15/2020309,900 shares $2.38 million +54.3%5.6%5 $7.69
6/30/2020200,800 shares $1.67 million +184.0%3.6%3.6 $8.31
6/15/202070,700 shares $671,650.00 +12.0%1.3%2.3 $9.50
5/29/202063,100 shares $831,027.00 +3.6%1.1%2.7 $13.17
5/15/202060,900 shares $801,444.00 +407.5%1.1%2.7 $13.16
4/30/202012,000 shares $170,520.00 +100.0%0.2%0.4 $14.21
4/15/20206,000 shares $100,200.00 -18.9%0.1%0.2 $16.70
3/31/20207,400 shares $110,482.00 -28.2%0.1%0.3 $14.93

NRBO Short Interest - Frequently Asked Questions

What is NeuroBo Pharmaceuticals' current short interest?

Short interest is the volume of NeuroBo Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of November 15th, investors have sold 34,300 shares of NRBO short. 1.14% of NeuroBo Pharmaceuticals' shares are currently sold short. Learn More on NeuroBo Pharmaceuticals' current short interest.

What is a good short interest ratio for NeuroBo Pharmaceuticals?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. NRBO shares currently have a short interest ratio of 1.0. Learn More on NeuroBo Pharmaceuticals's short interest ratio.

Which institutional investors are shorting NeuroBo Pharmaceuticals?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of NeuroBo Pharmaceuticals: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for NeuroBo Pharmaceuticals?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.14% of NeuroBo Pharmaceuticals' floating shares are currently sold short.

Is NeuroBo Pharmaceuticals' short interest increasing or decreasing?

NeuroBo Pharmaceuticals saw a increase in short interest during the month of November. As of November 15th, there was short interest totaling 34,300 shares, an increase of 78.6% from the previous total of 19,200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is NeuroBo Pharmaceuticals' float size?

NeuroBo Pharmaceuticals currently has issued a total of 8,616,000 shares. Some of NeuroBo Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. NeuroBo Pharmaceuticals currently has a public float of 3,000,000 shares.

How does NeuroBo Pharmaceuticals' short interest compare to its competitors?

1.14% of NeuroBo Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "banking" compare to NeuroBo Pharmaceuticals: Texas Community Bancshares, Inc. (0.10%), Catalyst Bancorp, Inc. (0.16%), CFSB Bancorp, Inc. (0.35%), OptimumBank Holdings, Inc. (0.19%), Digihost Technology Inc. (1.20%), Stronghold Digital Mining, Inc. (5.15%), Usio, Inc. (0.18%), Home Federal Bancorp, Inc. of Louisiana (0.24%), Binah Capital Group, Inc. (2.48%), Argo Blockchain plc (4.15%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($4.85 billion), Charter Communications, Inc. ($4.81 billion), International Paper ($2.96 billion), Cencora, Inc. ($2.40 billion), Paychex, Inc. ($2.38 billion), Lululemon Athletica Inc. ($2.05 billion), SoFi Technologies, Inc. ($2.03 billion), Live Nation Entertainment, Inc. ($1.93 billion), Onsemi ($1.82 billion), and Tractor Supply ($1.65 billion). View all of the most shorted stocks.

What does it mean to sell short NeuroBo Pharmaceuticals stock?

Short selling NRBO is an investing strategy that aims to generate trading profit from NeuroBo Pharmaceuticals as its price is falling. NRBO shares are trading up $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against NeuroBo Pharmaceuticals?

A short squeeze for NeuroBo Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of NRBO, which in turn drives the price of the stock up even further.

How often is NeuroBo Pharmaceuticals' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including NRBO, twice per month. The most recent reporting period available is November, 15 2024.



Related Companies
Short Interest Tools

This page (NASDAQ:NRBO) was last updated on 3/30/2025 by MarketBeat.com Staff
From Our Partners
Trump's 100-Day Plan Triggers Global Retaliation
In the final days of his first term, Trump quietly left open an "off the books" wealth-protection loophole hid...
American Alternative | Sponsored
Wall Street’s “AI Oracle” Reveals Next Big Tech Play
A tiny American tech company could be at the center of the next big AI breakthrough. Wall Street's "AI Orac...
InvestorPlace | Sponsored
A market crash is coming—here’s when
The stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...
Chaikin Analytics | Sponsored
Crypto Genius: 12,000% in 12 months? [Here’s how]
We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.
Paradigm Press | Sponsored
The Dirty Secret About Gold Mining Stocks...
Here's something most gold analysts won't tell you: 90% of gold mining companies actually destroy sharehold...
Golden Portfolio | Sponsored
Forget Trump’s Tariffs, This March Event Is Bigger
While everyone is distracted by Trump’s tariffs and a potential trade war… There’s something much bigger ha...
Brownstone Research | Sponsored
Termination: 18F (read immediately)
Have you ever heard of the government's 18F program? It helped manage digital services across the governmen...
Altimetry | Sponsored
Doomed: These 50 Stocks Will Die Under Trump’s MAGA policies.
Remember Kodak? Sears? Circuit City? They all failed to adapt to the changing times. Now, history is abo...
Banyan Hill Publishing | Sponsored